Detalhe da pesquisa
1.
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma.
Clin Transl Radiat Oncol
; 30: 95-99, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34458597